DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Hydralazine hydrochloride; hydrochlorothiazideis the generic ingredient in twenty-one branded drugs marketed by Novartis, Par Pharm, Solvay, Superpharm, Watson Labs, Ivax Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Sandoz, Sun Pharm Industries, and Lederle, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-one drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.
Recent Clinical Trials for hydralazine hydrochloride; hydrochlorothiazide
Identify potential brand extensions & 505(b)(2) entrants
|National Center for Research Resources (NCRR)||Phase 4|
|Vanderbilt University Medical Center||Phase 4|
|Vanderbilt University Medical Center||Phase 1/Phase 2|
Synonyms for hydralazine hydrochloride; hydrochlorothiazide